Related Experiment Videos
Cimetidine and fat malabsorption in children with cystic fibrosis
Insights
Cimetidine therapy in children with cystic fibrosis showed a potential improvement in fat and nitrogen absorption in some patients. However, group analysis did not confirm significant benefits, warranting further long-term studies.
Area of Science:
- Pediatric Gastroenterology
- Pharmacology
- Clinical Nutrition
Background:
- Cystic fibrosis (CF) is a genetic disorder affecting multiple organs, including the pancreas.
- Malabsorption, particularly of fats and nitrogen, is a common complication in CF due to pancreatic exocrine insufficiency.
- Standard enzyme replacement therapy is crucial, but optimizing nutrient absorption remains a clinical challenge.
Purpose of the Study:
- To investigate the efficacy of Cimetidine as an adjunct therapy in improving nutrient absorption in children with cystic fibrosis.
- To assess the impact of Cimetidine on fecal fat and nitrogen excretion in this patient population.
Main Methods:
- A cohort of 10 children diagnosed with cystic fibrosis participated in the study.
- Patients received a standardized diet and pancreatic enzyme preparation.
- Cimetidine was administered at a dosage of 600 mg/m2/day.
- Fecal fat and nitrogen excretion were analyzed over a 3-day period before and during Cimetidine treatment.
Main Results:
- Five out of ten patients exhibited an improvement in fat and nitrogen absorption after 6 days of Cimetidine therapy.
- Statistical analysis of the entire group did not reveal a significant improvement in overall fat absorption coefficients.
- Individual patient responses varied, suggesting potential heterogeneity in treatment effects.
Conclusions:
- Cimetidine may offer a potential benefit for a subset of children with cystic fibrosis experiencing malabsorption.
- The current data do not support the routine clinical recommendation of Cimetidine for improving absorption in CF patients.
- Further extensive, long-term clinical trials are necessary to validate the efficacy and safety of Cimetidine in this context.
Abstract:
Under controlled clinical observation we administered Cimetidine (600 mg/m2/day) in 10 children with cystic fibrosis. All patients received identical diets (40% fat, 45% carbohydrate, 15% protein) as well as same standardized enzyme preparation (lyophilised whole pancreas). 3-day fecal fat and nitrogen excretion analyses were performed. After 6 days of Cimetidine therapy, an improvement of fat and nitrogen absorption could be detected in 5 patients. Statistical analysis of the group as a whole showed no improvement in fat absorption coefficients. We conclude that this drug therapy should only be recommended for routine clinical use after long-term trials have shown a real improvement of absorption.